Ströhle A, Antonijevic I A, Steiger A, Sonntag A
Max-Planck-Institut für Psychiatrie, München.
Nervenarzt. 1999 Jan;70(1):72-5. doi: 10.1007/s001150050403.
With the introduction of the non-benzodiazepine hypnotics zopiclone and zolpidem it was expected to have hypnotics without side effects and risks characteristically seen with benzodiazepines. We report two cases with high-dose usage and dependency of non-benzodiazepine hypnotics. Both patients were prescribed the drugs to treat sleep disturbances occurring during a depressive episode. While one patient had a polysubstance abuse there was no evidence for an abuse history in the other patient. To reduce withdrawal symptoms long-acting benzodiazepines were given to both patients. Thus, it seems that not only patients with a history of substance abuse but also patients with a psychiatric disorder are at risk for abuse of non-benzodiazepine hypnotics. Considering the increasing number of case reports with abuse and dependence of zopiclone and zolpidem it seems necessary to reevaluate the dependency risk of the currently available non-benzodiazepine hypnotics.
随着非苯二氮䓬类催眠药佐匹克隆和唑吡坦的引入,人们期望能有一类没有苯二氮䓬类药物特有的副作用和风险的催眠药。我们报告两例高剂量使用和依赖非苯二氮䓬类催眠药的病例。两名患者均被处方此类药物以治疗抑郁发作期间出现的睡眠障碍。其中一名患者存在多种物质滥用情况,而另一名患者则没有药物滥用史的证据。为减轻戒断症状,两名患者均给予了长效苯二氮䓬类药物。因此,似乎不仅有物质滥用史的患者,而且患有精神疾病的患者也有滥用非苯二氮䓬类催眠药的风险。鉴于越来越多关于佐匹克隆和唑吡坦滥用及依赖的病例报告,重新评估目前可用的非苯二氮䓬类催眠药的依赖风险似乎很有必要。